Go Pro

Robert W. Baird Issues Positive Forecast for Veeva Systems (NYSE:VEEV) Stock Price

Veeva Systems logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Robert W. Baird raised Veeva Systems’ price target from $260 to $300 while maintaining an “outperform” rating, implying 5.35% upside from the prior close. The analyst move followed several other target increases, including RBC’s $325 target.
  • Veeva reported stronger-than-expected quarterly results, with revenue rising 17.6% year over year to approximately $928 million and EPS reaching $2.35 versus the $2.22 consensus estimate. Management also raised fiscal 2027 revenue and EPS guidance.
  • Shares jumped 16.3% to $284.77, but the stock’s premium valuation—around 50 times forward earnings—leaves it vulnerable to slower growth, weaker AI adoption, or disappointing future guidance.
  • Five stocks to consider instead of Veeva Systems.

Veeva Systems (NYSE:VEEV - Get Free Report) had its target price increased by investment analysts at Robert W. Baird from $260.00 to $300.00 in a note issued to investors on Thursday,Benzinga reports. The firm presently has an "outperform" rating on the technology company's stock. Robert W. Baird's target price would suggest a potential upside of 5.35% from the stock's previous close.

Several other research firms have also recently issued reports on VEEV. Raymond James Financial reissued an "outperform" rating and set a $225.00 target price on shares of Veeva Systems in a research note on Thursday, June 4th. Mizuho dropped their price target on Veeva Systems from $295.00 to $270.00 and set an "outperform" rating for the company in a research note on Thursday, June 4th. Stifel Nicolaus set a $300.00 price target on shares of Veeva Systems in a report on Thursday. Royal Bank Of Canada upped their price objective on shares of Veeva Systems from $275.00 to $325.00 and gave the stock an "outperform" rating in a report on Thursday. Finally, Weiss Ratings raised shares of Veeva Systems from a "hold (c-)" rating to a "hold (c)" rating in a research report on Wednesday, August 12th. Nineteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $280.58.

View Our Latest Research Report on Veeva Systems

Veeva Systems Stock Up 16.3%

Shares of NYSE:VEEV traded up $39.86 during midday trading on Thursday, hitting $284.77. 3,592,252 shares of the stock traded hands, compared to its average volume of 2,461,212. The stock has a market capitalization of $46.26 billion, a PE ratio of 50.74, a P/E/G ratio of 1.06 and a beta of 0.92. The business's 50 day moving average is $203.41 and its two-hundred day moving average is $183.04. Veeva Systems has a one year low of $148.05 and a one year high of $310.50.

Veeva Systems (NYSE:VEEV - Get Free Report) last posted its earnings results on Wednesday, August 26th. The technology company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.22 by $0.13. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.The company had revenue of $927.96 million for the quarter, compared to analysts' expectations of $905.38 million. During the same period last year, the firm earned $1.99 earnings per share. Veeva Systems's quarterly revenue was up 17.6% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. As a group, sell-side analysts forecast that Veeva Systems will post 6.65 earnings per share for the current year.

Insider Buying and Selling

In other news, insider Thomas D. Schwenger sold 36,000 shares of the business's stock in a transaction on Thursday, August 13th. The shares were sold at an average price of $250.23, for a total transaction of $9,008,280.00. Following the sale, the insider owned 19,449 shares in the company, valued at approximately $4,866,723.27. The trade was a 64.92% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 10.60% of the company's stock.

Hedge Funds Weigh In On Veeva Systems

A number of institutional investors and hedge funds have recently made changes to their positions in VEEV. Empire Life Investments Inc. boosted its stake in shares of Veeva Systems by 21.1% during the 4th quarter. Empire Life Investments Inc. now owns 37,054 shares of the technology company's stock worth $8,272,000 after acquiring an additional 6,453 shares during the last quarter. Czech National Bank bought a new position in Veeva Systems in the 2nd quarter worth $7,584,000. BNP Paribas lifted its position in Veeva Systems by 89.3% during the fourth quarter. BNP Paribas now owns 19,239 shares of the technology company's stock valued at $4,308,000 after purchasing an additional 9,077 shares in the last quarter. ABN Amro Investment Solutions increased its position in Veeva Systems by 28.4% in the fourth quarter. ABN Amro Investment Solutions now owns 76,809 shares of the technology company's stock worth $17,146,000 after buying an additional 17,007 shares in the last quarter. Finally, AustralianSuper Pty Ltd purchased a new position in shares of Veeva Systems during the 4th quarter valued at about $2,453,000. Institutional investors own 88.20% of the company's stock.

Veeva Systems News Roundup

Here are the key news stories impacting Veeva Systems this week:

  • Positive Sentiment: Fiscal Q2 revenue rose 17.6% year over year to approximately $928 million, exceeding the $905.4 million analyst consensus. Adjusted earnings of $2.35 per share also surpassed expectations of $2.22 and increased from $1.99 in the prior-year quarter. Veeva Systems Q2 Earnings and Revenues Beat Estimates, Stock Up
  • Positive Sentiment: Management raised fiscal 2027 guidance to approximately $3.7 billion in revenue and $9.21 in earnings per share, above consensus estimates of about $3.6 billion and $8.58, respectively. Third-quarter revenue guidance of $932 million to $935 million and EPS guidance of $2.33 to $2.34 also exceeded analyst expectations. Veeva Announces Fiscal 2027 Second Quarter Results
  • Positive Sentiment: Strong Vault CRM execution, including a record quarter, supported confidence that Veeva can maintain more than 70% market share. Falcon AI demand is building, with the company expecting its first customer go-lives this year. Veeva Targets Maintaining CRM Share as Falcon Go-Lives Begin
  • Positive Sentiment: Several analysts lifted their price targets following the results. RBC raised its target to $325 and kept an outperform rating, while Barclays raised its target to $315 with an overweight rating. Guggenheim and Truist also raised targets to $310 and $305, respectively.
  • Neutral Sentiment: Other analysts remained cautious despite raising targets: UBS set a $290 target with a neutral rating, Canaccord set $260 with a hold rating, and Morgan Stanley set $275 with an equal-weight rating. These targets indicate that some firms view much of the earnings optimism as already reflected in the stock.
  • Negative Sentiment: At a roughly 50.8 forward? P/E ratio as reported, Veeva carries a premium valuation, leaving the shares sensitive to any slowdown in growth, weaker AI adoption, or future guidance disappointments.

Veeva Systems Company Profile

(Get Free Report)

Veeva Systems NYSE: VEEV is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva's product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.

Further Reading

Analyst Recommendations for Veeva Systems (NYSE:VEEV)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Veeva Systems Right Now?

Before you consider Veeva Systems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veeva Systems wasn't on the list.

While Veeva Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines